Literature DB >> 22940070

Leukemic blasts with the paroxysmal nocturnal hemoglobinuria phenotype in children with acute lymphoblastic leukemia.

David J Araten1, Katie J Sanders, Dan Anscher, Leah Zamechek, Stephen P Hunger, Sherif Ibrahim.   

Abstract

It has been proposed that genomic instability is essential to account for the multiplicity of mutations often seen in malignancies. Using the X-linked PIG-A gene as a sentinel gene for spontaneous inactivating somatic mutations, we previously showed that healthy individuals harbor granulocytes with the PIG-A mutant (paroxysmal nocturnal hemoglobinuria) phenotype at a median frequency (f) of ∼12 × 10(-6). Herein, we used a similar approach to determine f in blast cells derived from 19 individuals with acute lymphoblastic leukemia (ALL) and in immortalized Epstein-Barr virus-transformed B-cell cultures (human B-lymphoblastoid cell lines) from 19 healthy donors. The B-lymphoblastoid cell lines exhibited a unimodal distribution, with a median f value of 11 × 10(-6). In contrast, analysis of the f values for the ALL samples revealed at least two distinct populations: one population, representing approximately half of the samples (n = 10), had a median f value of 13 × 10(-6), and the remaining samples (n = 9) had a median f value of 566 × 10(-6). We conclude that in ALL, there are two distinct phenotypes with respect to hypermutability, which we hypothesize will correlate with the number of pathogenic mutations required to produce the leukemia.
Copyright © 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22940070      PMCID: PMC3483812          DOI: 10.1016/j.ajpath.2012.07.025

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  48 in total

1.  Circulating PIG-A mutant T lymphocytes in healthy adults and patients with bone marrow failure syndromes.

Authors:  R E Ware; C V Pickens; C M DeCastro; T A Howard
Journal:  Exp Hematol       Date:  2001-12       Impact factor: 3.084

2.  Human lymphocytes resistant to 6-thioguanine increase with age.

Authors:  A A Morley; S Cox; R Holliday
Journal:  Mech Ageing Dev       Date:  1982-05       Impact factor: 5.432

3.  Improved detection and characterization of paroxysmal nocturnal hemoglobinuria using fluorescent aerolysin.

Authors:  R A Brodsky; G L Mukhina; S Li; K L Nelson; P L Chiurazzi; J T Buckley; M J Borowitz
Journal:  Am J Clin Pathol       Date:  2000-09       Impact factor: 2.493

4.  Glycophosphatidylinositol-anchored protein deficiency as a marker of mutator phenotypes in cancer.

Authors:  R Chen; J R Eshleman; R A Brodsky; M E Medof
Journal:  Cancer Res       Date:  2001-01-15       Impact factor: 12.701

5.  A mechanistic rationale for combining alemtuzumab and rituximab in the treatment of ALL.

Authors:  Bart A Nijmeijer; Marianke L J van Schie; Constantijn J M Halkes; Marieke Griffioen; Roelof Willemze; J H Frederik Falkenburg
Journal:  Blood       Date:  2010-09-15       Impact factor: 22.113

6.  Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells.

Authors:  Faiyaz Notta; Charles G Mullighan; Jean C Y Wang; Armando Poeppl; Sergei Doulatov; Letha A Phillips; Jing Ma; Mark D Minden; James R Downing; John E Dick
Journal:  Nature       Date:  2011-01-20       Impact factor: 49.962

7.  Estimation of mutation rate at human glycophorin A locus in hematopoietic stem cell progenitors.

Authors:  M A Vickers; T Hoy; H Lake; S Kyoizumi; J Boyse; M Hewitt
Journal:  Environ Mol Mutagen       Date:  2002       Impact factor: 3.216

8.  Dynamics of hematopoiesis in paroxysmal nocturnal hemoglobinuria (PNH): no evidence for intrinsic growth advantage of PNH clones.

Authors:  D J Araten; M Bessler; S McKenzie; H Castro-Malaspina; B H Childs; F Boulad; A Karadimitris; R Notaro; L Luzzatto
Journal:  Leukemia       Date:  2002-11       Impact factor: 11.528

Review 9.  The use of PIG-A as a sentinel gene for the study of the somatic mutation rate and of mutagenic agents in vivo.

Authors:  Benedetta Peruzzi; David J Araten; Rosario Notaro; Lucio Luzzatto
Journal:  Mutat Res       Date:  2009-12-24       Impact factor: 2.433

10.  FES-Cre targets phosphatidylinositol glycan class A (PIGA) inactivation to hematopoietic stem cells in the bone marrow.

Authors:  P Keller; J L Payne; G Tremml; P A Greer; M Gaboli; P P Pandolfi; M Bessler
Journal:  J Exp Med       Date:  2001-09-03       Impact factor: 14.307

View more
  3 in total

1.  The rate of spontaneous mutations in human myeloid cells.

Authors:  David J Araten; Ondrej Krejci; Kimberly Ditata; Mark Wunderlich; Katie J Sanders; Leah Zamechek; James C Mulloy
Journal:  Mutat Res       Date:  2013-06-06       Impact factor: 2.433

2.  MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia.

Authors:  Nikki A Evensen; P Pallavi Madhusoodhan; Julia Meyer; Jason Saliba; Ashfiyah Chowdhury; David J Araten; Jacob Nersting; Teena Bhatla; Tiffaney L Vincent; David Teachey; Stephen P Hunger; Jun Yang; Kjeld Schmiegelow; William L Carroll
Journal:  Haematologica       Date:  2018-02-15       Impact factor: 9.941

3.  Loss of the GPI-anchor in B-lymphoblastic leukemia by epigenetic downregulation of PIGH expression.

Authors:  Floris C Loeff; Kevin Rijs; Esther H M van Egmond; Willem H Zoutman; Xiaohang Qiao; Wilhelmina G M Kroes; Sabrina A J Veld; Marieke Griffioen; Maarten H Vermeer; Jacques Neefjes; J H Frederik Falkenburg; Constantijn J M Halkes; Inge Jedema
Journal:  Am J Hematol       Date:  2018-11-25       Impact factor: 10.047

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.